The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: A preliminary study of autocrine and paracrine loops
- 31 December 2006
- journal article
- Published by Elsevier in Research in Veterinary Science
- Vol. 81 (3) , 350-357
- https://doi.org/10.1016/j.rvsc.2006.01.007
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Anti-angiogenic therapy in breast cancerBiomedicine & Pharmacotherapy, 2003
- Prognostic Value of Vascular Endothelial Growth Factor in Breast CancerThe Oncologist, 2000
- High density of small vessels expressing the tyrosine kinase receptor KDRin primary invasive breast carcinoma correlates with axillary lymph node metastasesAngiogenesis, 1999
- Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loopsThe Journal of Pathology, 1998
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- Immunohistochemical detection of CD31 antigen in normal and neoplastic canine endothelial cellsJournal of Comparative Pathology, 1995
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.The Journal of Experimental Medicine, 1990
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971